Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Precore and Core Promoter Mutations Affecting HBV e Antigen Expression in Taiwan
Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Chao-Min Huang(Center for HIV and Hepatogastroenterology), Hock‐Liew Eng(Chang Gung University), Chi‐Sin Changchien(Kaohsiung Chang Gung Memorial Hospital), Chao‐Hung Hung(Kaohsiung Chang Gung Memorial Hospital), Sheng‐Nan Lu(Kaohsiung Chang Gung Memorial Hospital), Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital), Chuan–Mo Lee(Chang Gung University)
Cited by 102
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Hepatogastroenterology
|Hepatogastroenterology|2012|536